Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 78 | 3 | 2 | 1 | €264.00 | €331.61 | 25.611% |
| Eli Lilly Corp. | 72 | 2 | 7 | 1 | €792.80 | €991.05 | 25.007% |
| Gilead Sciences Inc | 54 | 0 | 2 | 0 | €117.38 | €124.33 | 5.924% |
| Intuitive Surgical Inc | 54 | 2 | 3 | 0 | €386.45 | €523.55 | 35.477% |
| Vertex Pharmaceuticals Inc. | 47 | 0 | 2 | 0 | €373.35 | €461.98 | 23.738% |
| HCA Holdings Inc. | 45 | 0 | 0 | 0 | €419.80 | €448.99 | 6.953% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 3 | 0 | €638.70 | €707.12 | 10.712% |
| Dexcom Inc. | 43 | 1 | 1 | 0 | €53.60 | €77.13 | 43.899% |
| Johnson & Johnson | 41 | 1 | 7 | 0 | €200.85 | €215.09 | 7.091% |
| Cigna Corp. | 37 | 0 | 0 | 0 | €231.40 | €311.96 | 34.814% |
| Medtronic plc | 37 | 1 | 4 | 0 | €74.28 | €95.57 | 28.662% |
| Thermo Fisher Scientific Inc. | 35 | 0 | 1 | 0 | €428.60 | €504.64 | 17.742% |
| AbbVie Inc. | 33 | 0 | 3 | 0 | €173.95 | €208.89 | 20.085% |
| Amgen Inc. | 34 | 3 | 1 | 0 | €296.95 | €305.71 | 2.951% |
| Edwards Lifesciences Corp. | 31 | 0 | 1 | 0 | €65.90 | €80.91 | 22.779% |
| Biogen Inc. | 29 | 0 | 4 | 0 | €147.76 | €181.48 | 22.822% |
| BioMarin Pharmaceutical Inc. | 28 | 0 | 1 | 0 | €46.43 | €80.63 | 73.666% |
| Agilent Technologies Inc. | 27 | 0 | 0 | 0 | €98.70 | €139.61 | 41.445% |
| Stryker Corp. | 23 | 0 | 2 | 0 | €291.70 | €353.50 | 21.185% |
| Elanco Animal Health Inc. | 23 | 0 | 0 | 0 | €19.39 | €23.60 | 21.709% |
| Exact Sciences | 22 | 0 | 0 | 0 | €90.74 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 22 | 0 | 1 | 0 | €26.00 | €31.83 | 22.426% |
| Align Technology | 21 | 0 | 1 | 0 | €146.20 | €175.92 | 20.328% |
| Resmed Inc. | 20 | 0 | 2 | 0 | €195.85 | €256.90 | 31.172% |
| Merck & Co. Inc. | 17 | 0 | 2 | 0 | €102.00 | €115.68 | 13.413% |